Company intelligence / Profile preview

Coastar Therapeutics

San Diego, CA, United Statescoastartherapeutics.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Coastar is in the pre-clinical stage with no published clinical results yet. Their ENHEnS™ platform has demonstrated potential in enabling systemic delivery of biologic drugs by shielding them from immune detection. The company is scaling up manufacturing and expanding R&D to advance toward clinical trials[8].

Therapeutic areas: OncologyRare DiseasesHematology
Modalities: Gene therapies (DNA, mRNA)Oncolytic virusesAAV vectorsProteinsNonviral gene delivery (eLNP with cell membrane)[2][6][8]
Industry: Biotech

Partnerships

SOHM, Inc. – collaboration on genome editing using red blood cell membrane-derived carriers [5].Multiple undisclosed biotech/pharma co-development partnerships for oncolytic viruses and gene therapies [8].

Beyond the preview

Go deeper on Coastar Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Coastar Therapeutics.

Explore the full profile